The New York Genome Center Awarded $13.5 Million from National Heart, Lung and Blood Institute for Whole Genome Sequencing
The New York Genome Center (NYGC) announced today that it was awarded a National Heart, Lung and Blood Institute (NHLBI) Whole Genome Sequencing and Omics Project for the Trans-Omics for Precision Medicine (TOPMed) Program contract of $13.5 million dollars for large-scale whole genome sequencing. NHLBI is part of The National Institutes of Health, the nation’s medical research agency—supporting scientific studies that turn discovery into health.
“NYGC has previously supported NHLBI’s TOPMed program, recently completing sequencing and analysis of 1,500 whole genomes,” said Soren Germer, Project Principal Investigator and Scientific Director, Sequencing Operations. “We are looking forward to continuing to support NHLBI’s goals through the next round of sequencing.”
The goals of the TOPMed Program include: Building a data commons repository for the scientific community to advance future research, furthering the discovery of fundamental mechanisms that underlie heart, lung, blood and sleep disorders, collecting WGS, –omics, and clinical outcome data across diverse populations and stimulating systems medicine approaches to organize data and ensure it is accessible and interpretable for health and disease research. NYGC is committed to providing the highest quality of whole genome sequencing to support NHLBI’s Precision Medicine Initiative.
By year end, NYGC will have sequenced over 10,000 genomes and has recently acquired four additional Hi-Seq X’s, bringing the total to 14, helping to support this project and other demand for high quality whole genome sequencing.
NYGC uses genomics to create actionable solutions for diseases. This is done in part, by working with NYGC Member Institutions and the genomics research community at large to provide best-in-class technology and expertise to advance scientific breakthroughs. NYGC’s genomics research services include experimental design assistance, sample quality control processes, library preparation, sequencing (whole genome, exome, RNA, and lane sequencing), extensive data quality control, bioinformatics, and data storage. Since moving into its permanent facility two years ago, NYGC has supported projects from over 90 institutions and companies and worked with hundreds of investigators, processing tens of thousands of samples.
For more information, please visit http://www.nhlbi.nih.gov/research/resources/nhlbi-precision-medicine-initiative/topmed.
About the New York Genome Center
The New York Genome Center (NYGC) is an independent, nonprofit at the forefront of transforming biomedical research and clinical care with the mission of saving lives. As a consortium of renowned academic, medical and industry leaders across the globe, NYGC focuses on translating genomic research into clinical solutions for serious disease. Our member organizations and partners are united in this unprecedented collaboration of technology, science, and medicine. We harness the power of innovation and discoveries to improve people’s lives – ethically, equitably, and urgently. Member institutions include: Albert Einstein College of Medicine, American Museum of Natural History, Cold Spring Harbor Laboratory, Columbia University College of Physicians and Surgeons, Cornell University/Weill Cornell Medicine, Hospital for Special Surgery, The Jackson Laboratory, Memorial Sloan- Kettering Cancer Center, Icahn School of Medicine at Mount Sinai, NewYork-Presbyterian Hospital, The New York Stem Cell Foundation, New York University, North Shore-LIJ, The Rockefeller University, Roswell Park Cancer Institute and Stony Brook University. For more information, visit: www.nygenome.org.
About the NHBLI
Part of the National Institutes of Health, the National Heart, Lung, and Blood Institute (NHLBI) plans, conducts, and supports research related to the causes, prevention, diagnosis, and treatment of heart, blood vessel, lung, and blood diseases; and sleep disorders. The Institute also administers national health education campaigns on women and heart disease, healthy weight for children, and other topics. NHLBI press releases and other materials are available online at http://www.nhlbi.nih.gov. For general information on TOPMed, please visit www.nhlbi.nih.gov/research/resources/nhlbi-pre.cision-medicine-initiative/topmed. Whole Genome Sequencing in TOPMed, please visit www.nhlbiwgs.org.